Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.

Literature DB >> 25820214

BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.

Jang-Hee Kim¹, Werner Paulus, Stephanie Heim.

Abstract

Entities: Disease Gene Mutation

Mesh：

Substances：

Year: 2015 PMID： 25820214 DOI： 10.1007/s11060-015-1757-6

Source DB: PubMed Journal: J Neurooncol ISSN： 0167-594X Impact factor: 4.130

× No keyword cloud information.

5 in total

1. Mutant enrichment with 3'-modified oligonucleotides a practical PCR method for detecting trace mutant DNAs.

Authors: Seung-Tae Lee; Ji-Youn Kim; Min-Jung Kown; Sun Wook Kim; Jae Hoon Chung; Myung-Ju Ahn; Young Lyun Oh; Jong-Won Kim; Chang-Seok Ki
Journal: J Mol Diagn Date: 2011-09-14 Impact factor: 5.568

Review 2. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships.

Authors: Gabriel Zada; Ning Lin; Eric Ojerholm; Shakti Ramkissoon; Edward R Laws
Journal: Neurosurg Focus Date: 2010-04 Impact factor: 4.047

3. Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia.

Authors: Robert T Jones; Malak S Abedalthagafi; Mohan Brahmandam; Edward A Greenfield; Mai P Hoang; David N Louis; Jason L Hornick; Sandro Santagata
Journal: Mod Pathol Date: 2014-11-21 Impact factor: 7.842

4. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Authors: Gad Singer; Robert Oldt; Yoram Cohen; Brant G Wang; David Sidransky; Robert J Kurman; Ie-Ming Shih
Journal: J Natl Cancer Inst Date: 2003-03-19 Impact factor: 13.506

5. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.

Authors: Priscilla K Brastianos; Amaro Taylor-Weiner; Peter E Manley; Robert T Jones; Dora Dias-Santagata; Aaron R Thorner; Michael S Lawrence; Fausto J Rodriguez; Lindsay A Bernardo; Laura Schubert; Ashwini Sunkavalli; Nick Shillingford; Monica L Calicchio; Hart G W Lidov; Hala Taha; Maria Martinez-Lage; Mariarita Santi; Phillip B Storm; John Y K Lee; James N Palmer; Nithin D Adappa; R Michael Scott; Ian F Dunn; Edward R Laws; Chip Stewart; Keith L Ligon; Mai P Hoang; Paul Van Hummelen; William C Hahn; David N Louis; Adam C Resnick; Mark W Kieran; Gad Getz; Sandro Santagata
Journal: Nat Genet Date: 2014-01-12 Impact factor: 38.330

5 in total

12 in total

1. Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells.

Authors: Gianluca Marucci; Dario de Biase; Matteo Zoli; Marco Faustini-Fustini; Antonella Bacci; Ernesto Pasquini; Michela Visani; Diego Mazzatenta; Giorgio Frank; Giovanni Tallini
Journal: Pituitary Date: 2015-12 Impact factor: 4.107

2. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.

Authors: Yuelong Wang; Jiaojiao Deng; Gang Guo; Aiping Tong; Xirui Peng; Haifeng Chen; Jianguo Xu; Yi Liu; Chao You; Liangxue Zhou
Journal: J Neurooncol Date: 2016-09-17 Impact factor: 4.130

3. Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.

Authors: Shannon Coy; Ziming Du; Shu-Hsien Sheu; Terri Woo; Fausto J Rodriguez; Mark W Kieran; Sandro Santagata
Journal: Mod Pathol Date: 2016-08-26 Impact factor: 7.842

Review 4. ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.

Authors: Priscilla K Brastianos; Sandro Santagata
Journal: Eur J Endocrinol Date: 2015-11-12 Impact factor: 6.664

5. BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series.

Authors: Emanuele La Corte; Iyan Younus; Francesca Pivari; Adelina Selimi; Malte Ottenhausen; Jonathan A Forbes; David J Pisapia; Georgiana A Dobri; Vijay K Anand; Theodore H Schwartz
Journal: Pituitary Date: 2018-12 Impact factor: 4.107

6. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.

Authors: Annett Hölsken; Martin Sill; Jessica Merkle; Leonille Schweizer; Michael Buchfelder; Jörg Flitsch; Rudolf Fahlbusch; Markus Metzler; Marcel Kool; Stefan M Pfister; Andreas von Deimling; David Capper; David T W Jones; Rolf Buslei
Journal: Acta Neuropathol Commun Date: 2016-02-29 Impact factor: 7.801